<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://prevencia.ro/stiri/cancer-gastroesofagian-sac-tmt-studiu</loc>
    <lastmod>2026-11-22T12:10:06.530Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-22T12:10:06.530Z</news:publication_date>
      <news:title>Cancer gastroesofagian avansat: MSD anunță un avantaj de supraviețuire cu sac-TMT, încă fără cifre</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/proteinoza-alveolara-molgramostim-decizie-fda</loc>
    <lastmod>2026-11-22T12:09:53.707Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-22T12:09:53.707Z</news:publication_date>
      <news:title>Proteinoza alveolară: decizia FDA privind molgramostim întârzie, anunță Savara</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/endometrioza-genetica-studiu-biobanci</loc>
    <lastmod>2026-11-22T12:09:39.153Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-22T12:09:39.153Z</news:publication_date>
      <news:title>Endometrioza: ce arată un studiu genetic pe peste un milion de femei despre mecanismele bolii</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/management-obezitate-medic-familie</loc>
    <lastmod>2026-11-21T10:06:56.317Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T10:06:56.317Z</news:publication_date>
      <news:title>Managementul obezității: rolul medicului de familie</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/distrofia-musculara-duchenne-deramiocel-fda</loc>
    <lastmod>2026-11-21T08:44:36.991Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T08:44:36.991Z</news:publication_date>
      <news:title>Distrofia musculară Duchenne: FDA refuză deramiocel și contestă datele studiului</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/tratamentul-tuberculozei-studiu-paradigm4tb</loc>
    <lastmod>2026-11-21T08:43:24.442Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T08:43:24.442Z</news:publication_date>
      <news:title>Tratamentul tuberculozei: două scheme de 16 săptămâni trec în etapa următoare a studiului</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/lipsa-medicamentelor-cnas-unifarm-acord</loc>
    <lastmod>2026-11-21T08:42:36.461Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T08:42:36.461Z</news:publication_date>
      <news:title>Lipsa medicamentelor: CNAS și Unifarm vor folosi datele de consum pentru aprovizionare</news:title>
    </news:news>
  </url>
</urlset>
